Reported 2 days ago
CVS Health's stock has plummeted by 32% this year due to disappointing earnings, increased medical expenses, and intense competition, particularly from Amazon. Despite its low valuation, uncertainties remain about the company's future performance and management's ability to navigate challenges. While it could represent a contrarian investment opportunity for risk-tolerant investors, many may prefer to wait for clearer signs of recovery under new leadership.
Source: YAHOO